Dr. Dulai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
259 E Erie St
Ste 1600
Chicago, IL 60611Phone+1 312-695-5620Fax+1 312-695-2729
Education & Training
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2017
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2010 - 2014
Dayanand Medical College Class of 2009
Certifications & Licensure
NH State Medical License 2013 - Present
IL State Medical License 2021 - 2026
CA State Medical License 2014 - 2023
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Sherman Emerging Leader Prize 2022
Clinical Trials
- Hyperbaric Oxygen for Ulcerative Colitis Start of enrollment: 2013 Aug 01
- Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares Start of enrollment: 2017 Sep 07
Publications & Presentations
PubMed
- Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and...Joana Torres, Julian Panés, Corey A Siegel, Marla C Dubinsky, Parambir S Dulai
The American Journal of Gastroenterology. 2025-03-17 - Spatially separated epithelium-associated and lamina propria neutrophils present distinct functional identities in the inflamed colon mucosa.Lenore K Yalom, Caroline J Herrnreiter, Triet M Bui, Joey Lockhart, Enzo B Piccolo
Mucosal Immunology. 2025-03-06 - Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease.Sunil Samnani, Emily C L Wong, Hasan Hamam, Parambir S Dulai, John K Marshall
Journal of Crohn's & Colitis. 2025-03-05
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel DiseasesWaseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
- Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis ConceptsParambir S Dulai, William J Sandborn, Brigid S Boland, Derek R Patel, Inflammatory Bowel Diseases
- Join now to see all
Press Mentions
Learn Best Practices for IBD Shared Decision-Making and Treatment SelectionFebruary 11th, 2025- Understanding a Novel Mechanism of Action in Ulcerative ColitisOctober 21st, 2024
- Oxygen Therapy Offers Promising Results in People with Crohn’s FistulasFebruary 1st, 2023
- Join now to see all
Grant Support
- Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled TrialNORTHWESTERN UNIVERSITY AT CHICAGO2023–2028
- Identifying Neutrophil Specific Mechanisms for Resistance to Biologics in Ulcerative ColitisNORTHWESTERN UNIVERSITY AT CHICAGO2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
